Elevai Labs (ELAB) said Thursday that its Elevai Biosciences subsidiary filed two patent applications for its lead candidate, EL-22, to treat muscle loss in obese patients.
Shares surged 52% as intraday trading volume soared to over 477.4 million from a daily average of about 4.9 million.
EVgo (EVGO) said Thursday it has received a conditional commitment for a loan guarantee of up to $1.05 billion from the US Department of Energy to expand its fast charging network.
Shares soared 59% as intraday trading volume catapulted to more than 100.2 million from a daily average of about 3.39 million.
RBC Capital raised its price target on Vistra (VST) to $141 from $105 while keeping its outperform rating.
Shares of Vistra climbed 6.8%, with intraday trading volume at over 10.3 million compared with a daily average of about 6.9 million.
Price: 0.13, Change: +0.04, Percent Change: +51.53
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。